Medicaid billing fraud investigations in New York often begin with a simple question: could the patient have actually received the billed service on that date? For New York providers, billing companies, transportation companies, clinics, home care agencies, and other Medicaid participants, that question can turn into a serious problem when claims appear under the names […]
Fraud
Facing NYC Department of Investigation Cases: How Norman Spencer Law Group Defends Clients
The New York City Department of Investigation (DOI) is a powerful and independent oversight body tasked with rooting out corruption, fraud, abuse, and misconduct within NYC government agencies and those doing business with the city. With its mandate covering city employees, contractors, vendors, and even elected officials, the DOI can initiate sweeping investigations with […]
Types of Healthcare Telemedicine Fraud
Telemedicine has transformed the healthcare industry by providing patients with access to medical services without the need for in-person visits. While this innovation has brought convenience and expanded care opportunities, it has also created new avenues for fraud. Telemedicine fraud schemes have been on the rise, particularly since the COVID-19 pandemic increased reliance on virtual […]
False Claims Act Federal Litigation in Government Programs and Grants
Introduction: The Impact of the False Claims Act on Federal Programs The False Claims Act (FCA) is one of the most potent legislative tools available to the federal government for combating fraud, particularly within government programs and grants. Originally enacted during the Civil War to prevent contractors from defrauding the Union Army, the FCA’s scope […]
Federal Money Laundering in the Healthcare Industry in New York: Legal Implications and How Norman Spencer Law Group Can Help
Money laundering is a grave federal offense, and in New York’s healthcare industry, it takes on additional layers of complexity due to the large sums involved in Medicaid and Medicare programs. With federal and state authorities increasingly scrutinizing healthcare providers, allegations of money laundering tied to fraudulent billing, kickbacks, or Medicaid fraud are not uncommon. […]
Gilead Sciences drug counterfeiting operation in New York
In August 2024, Gilead Sciences uncovered a large-scale drug counterfeiting operation in New York, involving two Queens-based pharmacies, 71st Rx and Finest Scripts. The company filed a lawsuit, accusing the pharmacies and their associates of trafficking counterfeit versions of Gilead’s HIV medications, notably Descovy and Biktarvy, which are widely used in both pre-exposure and post-exposure […]
